Works matching IS 03656233 AND DT 2004 AND VI 337 AND IP 6

Results: 7

[1, 2-Bis(2, 6-difluoro-3-hydroxyphenyl)ethylene-diamine]platinum(II) Complexes, Compounds for the Endocrine Therapy of Breast Cancer - Mode of Action II: Contribution of Drug Inactivation, Cellular Drug Uptake and Sterical Factors in the Drug-Target Interaction to the Antitumor Activity
Published in:
Archiv der Pharmazie, 2004, v. 337, n. 6, p. 349, doi. 10.1002/ardp.200300856
By:
- Sabine Schertl;
- Rolf W. Hartmann;
- Christine Batzl-Hartmann;
- Günther Bernhardt;
- Thilo Spruß;
- Karin Beckenlehner;
- Marion Koch;
- Rudolf Krauser;
- Richard Schlemmer;
- Helmut Schönenberger
Publication type:
Article
Contents: Archiv der Pharmazie 6/2004.
Published in:
Archiv der Pharmazie, 2004, v. 337, n. 6, p. 299, doi. 10.1002/ardp.200490007
Publication type:
Article
Intramolecular Distribution of Hydrophobicity Influences Pharmacological Activity of Propafenone-type MDR Modulators.
Published in:
Archiv der Pharmazie, 2004, v. 337, n. 6, p. 328, doi. 10.1002/ardp.200300862
By:
- Karin Pleban;
- Claudia Hoffer;
- Stephan Kopp;
- Michael Peer;
- Peter Chiba;
- Gerhard F. Ecker
Publication type:
Article
Lead Identification for Modulators of Multidrug Resistance based on in silico Screening with a Pharmacophoric Feature Model.
Published in:
Archiv der Pharmazie, 2004, v. 337, n. 6, p. 317, doi. 10.1002/ardp.200300817
By:
- Thierry Langer;
- Monika Eder;
- Remy D. Hoffmann;
- Peter Chiba
Publication type:
Article
New Antithrombotics with an Indazole StructurePart of the PhD thesis Ali Kemal Yildiz, FU Berlin, 2002.
Published in:
Archiv der Pharmazie, 2004, v. 337, n. 6, p. 311, doi. 10.1002/ardp.200300832
By:
- Ali Kemal Yildiz;
- Klaus Rehse;
- Johannes-Peter Stasch;
- Erwin Bischoff
Publication type:
Article
Synthesis of New 2-[1(2H)-Phthalazinon-2-yl]acetamide and 3-[1(2H)-Phthalazinon-2-yl]propanamide Derivatives as Antinociceptive and Anti-inflammatory Agents.
Published in:
Archiv der Pharmazie, 2004, v. 337, n. 6, p. 303, doi. 10.1002/ardp.200200719
By:
- Deniz S. Dogruer;
- Esra Kupeli;
- Erdem Yesilada;
- M. Fethi Sahin
Publication type:
Article
[1, 2-Bis(2, 6-difluoro-3-hydroxyphenyl)ethylene-diamine]platinum(II) Complexes, Compounds for the Endocrine Therapy of Breast Cancer - Mode of Action I: Antitumor Activity Due to the Reduction of the Endogenous Estrogen Level.
Published in:
Archiv der Pharmazie, 2004, v. 337, n. 6, p. 335, doi. 10.1002/ardp.200300855
By:
- Sabine Schertl;
- Rolf W. Hartmann;
- Christine Batzl-Hartmann;
- Günther Bernhardt;
- Thilo Spruß;
- Karin Beckenlehner;
- Marion Koch;
- Rudolf Krauser;
- Richard Schlemmer;
- Helmut Schönenberger
Publication type:
Article

Works matching IS 03656233 AND DT 2004 AND VI 337 AND IP 6

[1, 2-Bis(2, 6-difluoro-3-hydroxyphenyl)ethylene-diamine]platinum(II) Complexes, Compounds for the Endocrine Therapy of Breast Cancer - Mode of Action II: Contribution of Drug Inactivation, Cellular Drug Uptake and Sterical Factors in the Drug-Target Interaction to the Antitumor Activity

Contents: Archiv der Pharmazie 6/2004.

Intramolecular Distribution of Hydrophobicity Influences Pharmacological Activity of Propafenone-type MDR Modulators.

Lead Identification for Modulators of Multidrug Resistance based on in silico Screening with a Pharmacophoric Feature Model.

New Antithrombotics with an Indazole StructurePart of the PhD thesis Ali Kemal Yildiz, FU Berlin, 2002.

Synthesis of New 2-[1(2H)-Phthalazinon-2-yl]acetamide and 3-[1(2H)-Phthalazinon-2-yl]propanamide Derivatives as Antinociceptive and Anti-inflammatory Agents.

[1, 2-Bis(2, 6-difluoro-3-hydroxyphenyl)ethylene-diamine]platinum(II) Complexes, Compounds for the Endocrine Therapy of Breast Cancer - Mode of Action I: Antitumor Activity Due to the Reduction of the Endogenous Estrogen Level.